Zdrowie i gospodarka · 03/01/2005

FDA Releases Guidance on Submitting Separate Marketing Applications and Clinical Data for User Fee Purposes

The Food and Drug Administration (FDA) has announced the availability of a guidance document outlining its policy on separate marketing applications and clinical data for assessing user fees, aiming to clarify the agency's requirements for pharmaceutical companies.